|
FOCUS ON TRANSLATIONAL RESEARCH |
|
|
|
By Sanjeev Luther, Ernexa Therapeutics | Ernexa Therapeutics CEO Sanjeev Luther shares how clinical research has revealed why certain cancers resist treatment and how emerging cell therapies may help break through those defenses. | |
|
|
|
| Bridging Discovery And CMC With Rapid Pools | Webinar | Asimov | Learn how early stable CHO expression data reveals manufacturability issues in complex antibodies that transient screening misses, with case studies showing how this changes lead selection. |
|
|
|
|
TRANSLATIONAL RESEARCH SOLUTIONS |
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|